---
document_datetime: 2023-09-21 20:26:51
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/shingrix-epar-all-authorised-presentations_en.pdf
document_name: shingrix-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1105928
conversion_datetime: 2025-12-21 17:52:36.689575
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                                | Route of Administration   | Immediate Packaging                            | Content (concentration)           | Pack size                                 |
|------------------|-------------------|------------|----------------------------------------------------|---------------------------|------------------------------------------------|-----------------------------------|-------------------------------------------|
| EU/1/18/1272/001 | Shingrix          | --¹        | Powder and suspension for suspension for injection | Intramuscular use         | powder: vial (glass); suspension: vial (glass) | Powder: 50 µg; Suspension: 0.5 ml | 1 vial (powder) + 1 vial (suspension)     |
| EU/1/18/1272/002 | Shingrix          | --¹        | Powder and suspension for suspension for injection | Intramuscular use         | powder: vial (glass); suspension: vial (glass) | Powder: 50 µg; Suspension: 0.5 ml | 10 vials (powder) + 10 vials (suspension) |

--¹ After reconstitution, 1 dose (0.5 ml) contains 50 micrograms of gE antigen¹ adjuvanted with AS01B².

¹ Varicella Zoster Virus (VZV) glycoprotein E (gE) produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cells

² AS01B Adjuvant System is composed of the plant extract Quillaja saponaria Molina, fraction 21 (QS-21) (50 micrograms) and 3-O-desacyl-4'monophosphoryl lipid A (MPL) from Salmonella minnesota (50 micrograms)